SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Glial-Neuron Crosstalk in Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-glial-neuron-crosstalk-p
Related Entities
mechanisms-glial-neuron-crosstalk-parkinsons
Metadata
slugmechanisms-glial-neuron-crosstalk-parkinsons
entity_typemechanism
kg_node_idNone
Linked Artifacts (420)
mentions🧪LRP1-Dependent Tau Uptake Disruption71%
mentions🧪SASP-Mediated Complement Cascade Amplification70%
mentions🧪TREM2-mediated microglial tau clearance enhancement70%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy70%
mentions🧪Microbial Inflammasome Priming Prevention69%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming69%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%
mentions🧪Vagal Afferent Microbial Signal Modulation68%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri68%
mentions🧪Aquaporin-4 Polarization Rescue67%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation67%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal67%
mentions🧪Smartphone-Detected Motor Variability Correction66%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation66%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination65%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides65%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor65%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
related🧪APOE-TREM2 Interaction Modulation65%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub65%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor65%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri65%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy65%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy65%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia65%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition65%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi65%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists65%
related🧪Orexin-Microglia Modulation Therapy65%
related🧪Microglial Purinergic Reprogramming65%
related🧪Purinergic P2Y12 Inverse Agonist Therapy65%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination65%
related🧪TREM2-mediated microglial tau clearance enhancement65%
related🧪TREM2-Dependent Microglial Senescence Transition65%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli65%
related🧪LRP1-Dependent Tau Uptake Disruption64%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade64%
related🧪SASP-Mediated Complement Cascade Amplification63%
mentions🧪Vocal Cord Neuroplasticity Stimulation63%
related🧪TREM2-mediated microglial tau clearance enhancement63%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy63%
related🧪Microbial Inflammasome Priming Prevention62%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming62%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna62%
related🧪Vagal Afferent Microbial Signal Modulation61%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri61%
related🧪Aquaporin-4 Polarization Rescue60%
related🧪SASP-Driven Aquaporin-4 Dysregulation60%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related🧪Smartphone-Detected Motor Variability Correction59%
related🧪Circadian-Synchronized LRP1 Pathway Activation59%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination59%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides59%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor58%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation58%
related🧪APOE-TREM2 Interaction Modulation58%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub58%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy58%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia58%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition58%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi58%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists58%
related🧪Orexin-Microglia Modulation Therapy58%
related🧪Microglial Purinergic Reprogramming58%
related🧪Purinergic P2Y12 Inverse Agonist Therapy58%
related🧪TREM2-Dependent Microglial Senescence Transition58%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli58%
related🧪Enteric Nervous System Prion-Like Propagation Blockade57%
related🧪Vocal Cord Neuroplasticity Stimulation56%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro50%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model50%
mentions🧫Leukocyte gene expression analysis in COVID-19 patients50%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise50%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy50%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim50%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia50%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease50%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway50%
see_also📖Alzheimer's Disease Biomarkers45%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease45%
see_also📖Digital Biomarkers for Alzheimer's Disease45%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease45%
see_also📖DTI Biomarkers for Alzheimer's Disease45%
see_also📖EEG Biomarkers for Alzheimer's Disease45%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease45%
see_also📖Gait Biomarkers for Alzheimer's Disease45%
see_also📖GFAP in Alzheimer's Disease45%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease45%
see_also📖Neurogranin - Alzheimer's Disease Biomarker45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease45%
see_also📖Olfactory Biomarkers for Alzheimer's Disease45%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'45%
see_also📖Salivary Biomarkers for Alzheimer's Disease45%
see_also📖Sleep Biomarkers for Alzheimer's Disease45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖Synaptic Biomarkers for Alzheimer's Disease45%
see_also📖Tear Film Biomarkers in Alzheimer's Disease45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease45%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)45%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh45%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05645%
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer45%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease45%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease45%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease45%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT045%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer45%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di45%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636245%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea45%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease45%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0645%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas45%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543645%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083345%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D45%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise45%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 45%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease45%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease45%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)45%
see_also📖Masupirdine for Alzheimer's Disease Agitation45%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0545%
see_also📖MK-2214 for Early Alzheimer's Disease45%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451645%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease45%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 45%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT045%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)45%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 45%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N45%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0645%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%
see_also📖Master Screening Study to Determine Individuals With Potenti45%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)45%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer45%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'45%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial45%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease45%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A45%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe45%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)45%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis45%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)45%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's45%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise45%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)45%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease45%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424145%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)45%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)45%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime45%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention45%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'45%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial45%
see_also📖Alzheimer's Disease Mechanism Index45%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease45%
see_also📖APOE4 and Alzheimer's Disease Risk45%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP45%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca45%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease45%
see_also📖EEG Microstates in Alzheimer's Disease45%
see_also📖Endolysosomal Pathway in Alzheimer's Disease45%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t45%
see_also📖Glymphatic System in Alzheimer's Disease45%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease45%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease45%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa45%
see_also📖Neuroinflammation in Alzheimer's Disease45%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ45%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease45%
see_also📖Senescent Cell Clearance in Neurodegeneration45%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Sporadic Alzheimer's Disease Pathway45%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease45%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease45%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 45%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's45%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 44%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 44%
mentions🧫NPH Glymphatic System Interaction Experiment44%
mentions🧫Dexamethasone treatment study in α-synuclein mice44%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice44%
mentions🧫TLR expression in α-synuclein overexpressing mice44%
mentions🧫TLR expression analysis in Parkinson's disease patients44%
mentions🧫TLR4 Activation Assay with NETs and Anti-CarP Antibodies44%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying selective vulnerability o40%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬What are the mechanisms underlying neuroinflammation resolut40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬What are the mechanisms underlying sleep disruption as cause40%
mentions🔬What are the mechanisms underlying rna binding protein dysre40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%
mentions🔬What are the mechanisms underlying perivascular spaces and g40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪The Glial Ketone Metabolic Shunt Hypothesis35%
related🧪Glial Glycocalyx Remodeling Therapy35%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation35%
related🧪APOE Isoform Expression Across Glial Subtypes35%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub